Prophylactic veno-arterial extracorporeal membrane oxygenation in patients undergoing high-risk percutaneous coronary intervention.
Chronic total occlusion
High-risk percutaneous coronary intervention
Percutaneous coronary intervention
Veno-arterial extracorporeal membrane oxygenation
Journal
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
ISSN: 1568-5888
Titre abrégé: Neth Heart J
Pays: Netherlands
ID NLM: 101095458
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
pubmed:
30
11
2019
medline:
30
11
2019
entrez:
30
11
2019
Statut:
ppublish
Résumé
Complex high-risk percutaneous coronary intervention (PCI) is challenging and frequently accompanied by haemodynamic instability. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) can provide cardiopulmonary support in high-risk PCI. However, the outcome is unclear. A two-centre, retrospective study was performed of all patients undergoing high-risk PCI and receiving VA-ECMO for cardiopulmonary support. A total of 14 patients (92% male, median age 69 (53-83) years), of whom 50% had previous coronary artery disease in the form of a coronary artery bypass graft (36%) and a PCI (14%) underwent high-risk PCI and received VA-ECMO support. The main target lesion was a left main coronary artery in 78%, a left anterior descending artery in 14%, a right coronary artery in 7%, and 71% underwent multi-vessel PCI in addition to main target vessel PCI. The median SYNTAX score was 27.2 (8-42.5) and in 64% (9/14) there was a chronic total occlusion. Left ventricular function was mildly impaired in 7% (1/14), moderately impaired in 14% (2/14) and severely impaired in 64% (9/14). Cannulation was femoral-femoral in all patients. Median ECMO run was 2.57 h (1-4). Survival was 93% (13/14). One patient died during hospitalisation due to refractory cardiac failure. All other patients survived to discharge. Complications occurred in 14% (2/14), with one patient developing a transient ischaemic attack post-ECMO and one patient developing a thrombus in the femoral vein used for ECMO cannulation. VA-ECMO in high-risk PCI is feasible with a good outcome. It can be successfully used for cardiopulmonary support in selected patients.
Identifiants
pubmed: 31782108
doi: 10.1007/s12471-019-01350-8
pii: 10.1007/s12471-019-01350-8
pmc: PMC7052097
doi:
Types de publication
Journal Article
Langues
eng
Pagination
139-144Références
Heart Lung. 2015 Jul-Aug;44(4):309-13
pubmed: 25913808
Circulation. 2013 Jan 15;127(2):207-12
pubmed: 23224207
JACC Cardiovasc Interv. 2015 Nov;8(13):1772-4
pubmed: 26585627
J Card Fail. 2015 Jun;21(6):499-518
pubmed: 26036425
Eur J Cardiothorac Surg. 1999 Jun;15(6):816-22; discussion 822-3
pubmed: 10431864
EuroIntervention. 2017 Feb 20;12(14):1689-1696
pubmed: 28216471
Neth Heart J. 2018 Feb;26(2):76-84
pubmed: 29260464
EuroIntervention. 2019 Aug 29;15(5):427-433
pubmed: 30741638
Lancet. 2013 Feb 23;381(9867):629-38
pubmed: 23439102
N Engl J Med. 2009 Mar 5;360(10):961-72
pubmed: 19228612
Eur Heart J. 2009 Sep;30(17):2102-8
pubmed: 19617601
Kidney Int. 2011 Jul;80(1):17-28
pubmed: 21150873
Crit Care Med. 2010 Jan;38(1):152-60
pubmed: 19770739
J Interv Cardiol. 2015 Feb;28(1):32-40
pubmed: 25689546
Eur J Echocardiogr. 2006 Mar;7(2):79-108
pubmed: 16458610
J Am Coll Cardiol. 2019 Feb 19;73(6):654-662
pubmed: 30765031
Eur Heart J. 2014 Oct 1;35(37):2541-619
pubmed: 25173339
JAMA. 1985 Mar 8;253(10):1420-6
pubmed: 3968772
Clin Res Cardiol. 2016 Apr;105(4):283-96
pubmed: 26608160
Am J Cardiol. 2016 Aug 1;118(3):369-75
pubmed: 27265673
Heart Lung. 2016 Nov - Dec;45(6):532-537
pubmed: 27601212
J Invasive Cardiol. 2016 Feb;28(2):52-7
pubmed: 26689415
Curr Cardiol Rep. 2014 Dec;16(12):544
pubmed: 25326728